214610 — MiCo BioMed Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for MiCo BioMed Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-5,776	-10,585	-38,919	-25,795	-31,803
Depreciation
Amortisation
Non-Cash Items	10,033	5,557	22,195	15,369	17,471
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-24,712	-6,011	-128	-3,243	1,552
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-18,679	-8,600	-14,006	-11,359	-10,696
Capital Expenditures	-6,022	-3,131	-1,661	-681	-987
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-3,705	-9,464	-10,867	-7,883	7,093
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-9,727	-12,595	-12,528	-8,565	6,107
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	39,789	23,733	8,327	23,587	8,894
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	11,250	2,956	-18,133	3,676	4,319